Europe aims to snag title of world s premier hotspot for life sciences

BAKU, Azerbaijan, July 10. The European Commission has launched a new Life Sciences Strategy designed to establish Europe as the world’s most attractive destination for life sciences innovation by 2030, Trend reports.

The strategy delineates an allocation exceeding 10 billion euros per annum from the extant EU fiscal framework and advocates for a synergistic methodology encompassing the comprehensive value chain of the industry.
The strategic framework is designed to catalyze scientific advancements, streamline pathways for expedited market entry, and enhance public confidence in emerging technologies, thereby guaranteeing that their advantages are disseminated to both humanity and the ecosystem.

“The European Life Sciences Strategy is highly significant for Lithuania. We already have a strong and innovative life sciences community contributing to our national GDP. But there’s room to grow—and utilizing EU financial tools more intensively is one of the ways to unlock this potential. These instruments will help make both Europe and Lithuania top destinations for advancing life sciences,” said Marius Vaščega, Head of the European Commission Representation in Lithuania.

Key measures in the strategy include optimizing research and innovation ecosystems, improving the speed at which life sciences innovations reach the market, and supporting public acceptance and adoption of new solutions.

The European Commission will introduce a dedicated EU investment plan to support large-scale clinical trials and strengthen Europe’s clinical research infrastructure. The strategy also promotes the “One Health” approach in research and innovation and allocates up to 100 million euros through the 2026–2027 Horizon Europe program for microbiome-based solutions.

An incremental allocation of 250 million euros will be directed towards cross-disciplinary life sciences technologies, facilitating sustainable industrial innovation, pioneering conceptual frameworks, novel molecular entities, cutting-edge materials, and enhanced biotech-driven manufacturing processes.
In order to catalyze the innovation ecosystem, the Commission is set to introduce a comprehensive EU Biotechnology Act designed to establish a more conducive regulatory architecture across various biotech domains. A novel matchmaking ecosystem is set to be deployed, facilitating synergies among startups, industry stakeholders, and capital investors.
An additional 300 million euros will be allocated to catalyze innovation-centric public procurement in domains including climate resilience, advanced vaccine development, and cost-effective oncology interventions. A Life Sciences Coordination Group will be instituted to synergize policy and funding across diverse sectors and to facilitate collaborative engagement among pivotal stakeholders, encompassing both industry and the citizenry.
The life sciences sector currently generates approximately 1.5 trillion euros in incremental value within the EU economic landscape and underpins the employment of 29 million individuals. Through the implementation of this strategic framework, the EU seeks to reinforce its preeminence on the global stage while cultivating enduring resilience, sustainability, and advancements in health innovation throughout its member states.

Stay up-to-date with more news on Trend News Agency's WhatsApp channel